top of page
it's where dermatology lives




1/2


Dormant melanocytes may offer new treatment path in vitiligo
Under normal conditions (left), melanocytes adhere to laminin-211 in the basement membrane through dystroglycan, maintaining their mature pigment-producing state. In vitiligo (right), remodeling of the basement membrane increases laminin-332 and promotes integrin α3β1-mediated adhesion, activating signalling pathways, including c-Jun, that drive melanocyte dedifferentiation and loss of pigment production. Image courtesy Osaka Metropolitan University Researchers report that pi
Allan Ryan
Aug 172 min read


JAK inhibitors for alopecia areata
Photo by Thirunavukkarasye-Raveendran via Wikimedia Commons JAK inhibitors are emerging as effective treatments for alopecia areata, said...
Mitch Shannon
Nov 1, 20243 min read
TEN treated successfully with JAK inhibitor
Researchers have successfully treated seven patients experiencing toxic epidermal necrolysis (TEN) using JAK inhibitors. All seven...
John Evans
Oct 18, 20242 min read


Abrocitinib improves chronic itching conditions
New research shows that the Janus kinase (JAK) inhibitor abrocitinib, approved in Canada for the treatment of moderate-to-severe atopic...
John Evans
Jun 14, 20242 min read


Precise design of JAK inhibitors may improve outcomes in variety of diseases
A study from the Icahn School of Medicine at Mount Sinai in New York has reported some new insights into JAK inhibitors. While current...
Allan Ryan
Jan 15, 20242 min read


JAK inhibitors may treat eosinophilic cellulitis
New findings suggest that eosinophilic cellulitis (EC) preferentially activates the Janus kinase (JAK) 1/JAK2-STAT5 pathways. The...
John Evans
Jun 23, 20231 min read


Disabling pansclerotic morphea treated with ruxolitinib
Researchers have identified genomic variants that cause disabling pansclerotic morphea and have identified a treatment for the rare,...
John Evans
Jun 2, 20233 min read


Oral JAK inhibitor treats adolescent alopecia areata
New findings show that the oral Janus kinase (JAK) inhibitor ritlecitinib effectively treats alopecia areata in adolescents. The study...
John Evans
Apr 21, 20231 min read
Featured Posts


bottom of page
